Chi Energizer 10 speeds CE FDA 110V/220V

Product name : Chi Energizer 10 speeds CE FDA 110V/220V

Item : RBETF001H

Price : USD239.95 per set Free Shipping (Sample Price)

Details :

New Fashionable Design Foot Machine (ETF001H) with infrared, heating, swing function to care your health!! Chi Energizer, 10 speeds  High Quality Chi Energizer,CE FDA certified. Special swing motions relaxes and stimulates human body;  Vibration board to do foot massage in helping increase of human immunity;  Infrared heating included;  LCD remote controller;  5,10,15 minutes for choice;  8 speed levels available for swinging;  2 speed levels avaible for vibration;  Blow-resistant ABS-synthetic material.  Voltage: 110V-120V 60Hz or 220-230V 50Hz  Rated power: 45W  Net weight: 7 KGS  Gift: Waist Twisting DISC & Yoga Mat Waist Twisting DISC(1 piece) Sample Order, Please Click Here  Press the above button to pay. Wholesale, Please Click Here

Immunomodulatory effects of blood letting cupping therapy in patients with rheumatoid arthritis

Department of Microbiology, Faculty of Medicine For Girls, Al-Azhar University, Cairo, Egypt.

Abstract

This study was carried out in order to evaluate the efficiency of blood-letting cupping (BLC) therapy as a complementary therapy in management of rheumatoid arthritis (RA) and to investigate its modulatory effects on natural killer cells (NK) and soluble interleukin-2 receptor (SIL-2R). Two groups of RA patients diagnosed according to American Rheumatology Association were included: Group I included 20 patients who received the conventional medicinal therapy of RA, Group II included 30 patients who received combined conventional and BLC therapy. Ten age and sex matched normal controls were also included, as group III. Visual analogue score (VAS), tender joint count (TJC), swollen joint count (SJC), disease activity scores (DAS), laboratory markers of disease activity [erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), Rheumatoid factor (RF)] were evaluated on 3 successive months, NK cell (%) measured by flowcytometry and SIL-2R concentrations measured by ELISA were also assessed. After one month of combined therapy there was significant (P < 0.001) reduction in VAS (5.16 +/- 0.28), TJC (11.62 +/- 1.03), SJC (10.13 +/- 1.02) and DAS (5.35 +/- 0.14). Early and marked reductions in laboratory markers of disease activity (26.90 +/- 3.68) for CRP, (51.46 +/- 6.06) for RF and (40.56 +/-3.36) for ESR were also detected as compared to base line, while the effects of conventional therapy appeared late after 3 months of treatment. Conventional therapy induced significant depression in white blood cell (WBC %) (p < 0.001) whereas combined therapy induced marked (p < 0.001) elevation since the first month (8.44 +/- 1.58) compared to base line (6.94 +/- 1.58). There was a significant (P < 0.05) lowering in NK cell (%) with conventional therapy while combined therapy induced significant (P < 0.001) increase (11.33 +/- 0.4.7) compared to base line level (8.50 +/- 0.46). Additionally, combined therapy resulted in marked reduction (P < 0.001) in SIL-2R conc. after 3 months of treatment (1790 +/- 68.11) compared to base line (2023 +/- 92.95), while insignificant reduction was detected with the conventional therapy. The improvement rate (%) of clinical, laboratory cellular & immunological parameters were significantly higher with combined therapy than with conventional therapy. Moreover, strong positive correlations (p < 0.0001) were detected between SIL-R conc. and clinical parameters VAS (r = 0.890), TJC (r = 0.905), SJC (r = 0.872) and DAS (r = 0.923) and also between SIL-R conc. and ESR (r = 0.973), CRP (r = 0.933), RF (r = 0.941), while a strong negative correlation was found with NK count cell % (r = 0.927). In conclusion, BLC therapy combined with conventional therapy may improve the clinical condition of patients with RA. It has modulatory effects on the innate (NK %) and adaptive cellular (SIL-2R conc.) immune responses that could be used as monitoring tools for disease activity and prognosis.

The efficacy of wet-cupping in the treatment of tension and migraine headache

Kermanshah University of Medical Sciences, Iran.

Abstract

Wet-cupping is an ancient medical technique still used in several contemporary societies, but little empirical study has been devoted to test its efficacy to treat tension and migraine headache. Using a pre-post research design, 70 patients with chronic tension or migraine headache were treated with wet-cupping. Three primary outcome measures were considered at the baseline and 3 months following treatment: headache severity, days of headache per month, and use of medication. Results suggest that, compared to the baseline, mean headache severity decreased by 66% following wet-cupping treatment. Treated patients also experienced the equivalent of 12.6 fewer days of headache per month. We conclude that wet-cupping leads to clinical relevant benefits for primary care patients with headache. Possible mechanisms of wet-cupping's efficacy, as well as directions for future research are discussed.

Online Shop Of Alternative Health Medicine and Traditional Chinese Medicine Product By ALIBABA

As RightBest Medic Company is a professional factory and export of  Alternative Health Medicine and Traditional Chinese Medicine product for many years,we provide OEM and ODM service for global customers.

And now,we could provide retail order service,with reasonable price and high quality products, help more people to get health care service.

Our online shop is http://www.aliexpress.com/store/129273 .

( Part of Alibaba.com, AliExpress offers minimum orders as low as 1 item, buyer protection and express delivery with full tracking)